Researchers sought to determine whether first-line brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine would yield favorable results in HL.
Hodgkin lymphoma patients treated with subdiaphragmatic radiation and/or procarbazine have an increased risk of developing colorectal cancer, a study suggests.
Researchers sought to determine whether lisocabtagene maraleucel would improve health-related quality of life in patients with relapsed/refractory LBCL.
Researchers sought to determine whether a novel clinical prediction model would be able to determine patient prognosis in advanced-stage classical Hodgkin lymphoma.
Researchers sought to determine whether combining nivolumab with chemotherapy and radiotherapy would be effective in early-stage, unfavorable Hodgkin lymphoma.
A retrospective analysis sought to determine safety and tolerability of posttransplantation cyclophosphamide in patients with peripheral T-cell lymphoma.
Lunsumio is a first-in-class CD20xCD3 T-cell engaging bispecific antibody that targets CD20 on the surface of B cells and CD3 on the surface of T cells.
Adding ibrutinib to induction and maintenance after transplant improves failure-free survival in patients with mantle cell lymphoma, results of the TRIANGLE study suggest.
The combination of zandelisib and zanubrutinib produced high overall response rates in patients with relapsed/refractory follicular lymphoma or mantle cell lymphoma.
A single-institution retrospective study identified characteristics of patients with cutaneous T-cell lymphoma at higher risk of sepsis morbidity and mortality.
Researchers sought to determine whether tisagenlecleucel would improve clinical outcomes compared with usual care among patients with relapsed or refractory FL.
Researchers sought to determine whether whole brain radiotherapy after induction chemotherapy would improve outcomes in patients with primary CNS lymphoma.